106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
For additional copies, order at GuidelineCentral.com
Copyright © 2016 All rights reserved
AGACROALG16083
Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient care.
It is applicable to specialists, primary care, and providers at all levels. is Guideline should not be
considered exclusive of other methods of care reasonably directed at obtaining the same results. e
ultimate judgment concerning the propriety of any course of conduct must be made by the clinician
aer consideration of each individual patient situation. Neither IGC, the medical associations, nor the
authors endorse any product or service associated with the distributor of this clinical reference tool.
Abbreviations
AGA, American Gastroenterological Association Institute; AZA, azathioprene; CBC, complete
blood count; CMP, Comprehensive metabolic panel; CRP, C-reactive protein; ESR, erythrocyte
sedimentation rate; MTX, methotrexate; TNF, tumor necrosis factor
Source
Sandborn WJ. Crohn's Disease Evaluation and Treatment: Clinical Decision Tool.
Gastroenterolog y 2014;147:702-705.
AGA Institute Care Pathway for the Identification,
Assessment and Initial Medical Treatment in Crohn's Disease
Visit gastro.org/guidelinesapp to learn about the AGA Clinical Guidelines App.
Available for download on the iTunes and Google Play Store.
